People with diabetes have up to 3 times the risk of heart and kidney comorbidities! Taiwan's "1 Care Concept" Leads the World: Reduces Patients' Medical Expenditures
More than 10% of Taiwan’s diabetic population seeks medical treatment! Taiwan leads the world in launching the concept of “precision health education”
The number of people seeking medical treatment for diabetes in Taiwan is as high as 2.42 million, accounting for more than 10% of Taiwan’s total population. What is even more worrying is that diabetes has many comorbidities, among which cardiovascular disease and nephropathy have a high proportion and a huge impact. However, each patient’s condition is different. If the risk of comorbidities can be accurately assessed and prevented early, there will be an opportunity to improve the quality of care and reduce unnecessary medical burden.
The international view of precision medicine is still limited to “late-stage treatment”, but Taiwan leads the world in proposing a new concept of “precision health education”, which analyzes each patient’s disease course, possible comorbidities and severity, and provides relevant treatment. The corresponding health education content is expected to be precise from the early prevention and care stages.
The National Institutes of Health, the Diabetes Health Education Association of Taiwan, and Taiwan’s AstraZeneca signed a memorandum of cooperation on the “2025 Diabetes Precision Health Education Plan” on May 31. They look forward to promoting “precision health education” to Empowering the care team and improving patients’ awareness of self-care while achieving the goal of preventing comorbidities will further improve Taiwan’s diabetes health education system and improve patients’ quality of life.
People with diabetes are up to 3 times more likely to develop heart and kidney disease! Precision health education concept helps reduce medical expenses
According to statistics from the Central Health Insurance Administration of the Ministry of Health and Welfare, the number of medical visits due to diabetes in 2020 has reached 2.42 million. Diabetes has many comorbidities and has far-reaching consequences. Xu Huiheng, deputy director of the National Institutes of Health, shared that patients with diabetes have a higher chance of suffering from coronary heart disease than the average person. 2 times, and the chance of stroke is also 3 times higher than that of the average person.
Cardiovascular disease has become the main cause of death among diabetic patients in recent years, and kidney disease cannot be underestimated. One out of every three people with diabetes will develop chronic kidney disease. Therefore, early prevention of comorbidities is very important. It can not only reduce the overall course of the disease in the long term The cost helps patients maintain a good quality of life!
However, even with the same disease, different diabetic patients will require corresponding treatments based on their physical conditions. Therefore, precision medicine has become a major trend. Director of the National Health Research Institutes of Taiwan, Situ Huikang, said that when promoting precision medicine internationally, most emphasis is on treatment, but in fact, early preventive health education also needs to be more personalized according to the patient’s condition. For example, National Health Research Institutes of Taiwan At this stage, it is investing in the research and development of a diabetes comorbidity prediction platform, using data to calculate and compare comorbidity risks to provide a precise medical care model.
Secretary-General Ou Hongyi further explained that in the past, patients with diabetes needed to take into account the prevention of kidney and heart comorbidities, and may have to consider multi-faceted lifestyle adjustments and treatments at the same time. However, with the assistance of precision health education tools, patients can help predict the incidence of different comorbidities. and order, and be prepared in advance.
Care team empowerment and early prevention of comorbidities move towards the era of precision diabetes education
In line with the trend of precision health education, the National Institutes of Health, the Diabetes Health Education Association of Taiwan, and Taiwan’s AstraZeneca jointly launched the “2025 Diabetes Precision Health Education Plan.” Chairman Wang Zhiyuan said that this plan will focus on three aspects: General reinforcement:
Empowerment of the care team: The actual application of precision health education tools relies on the professionalism and input of health teachers. Therefore, the importance of health teachers in the care process will be greatly enhanced, the role of health teachers will be strengthened, and cross-team experience will be promoted comminicate.
Patient-centered: Precision health education will change the past concept of care. In addition to more patient-centered personalized health management, it will also improve patients’ self-care abilities and implement equal rights in care.
Early prevention of comorbidities: Accurately detect risks such as kidney disease and cardiovascular disease, and develop the most suitable personalized prevention, treatment and care methods for comorbidities, thereby improving medical efficiency and patients’ quality of life.
Chairman Wang Zhiyuan said that overall, the precision health education plan will help implement personalized health management, provide systematic and close-to-need health education resources for different patient groups, and thereby avoid the occurrence of more comorbidities. Improve patients’ quality of life. Diabetes care requires active investment from all walks of life. Through the signing of the memorandum of cooperation between the National Institutes of Health, the Diabetes Health Education Association, and Taiwan AZ, we look forward to improving the self-care capabilities of diabetic patients and preventing comorbidities through industry-government-academic cooperation, and in line with Taiwan government policies Driven by the integration, we will expand the international visibility of Taiwan’s good care quality.
Further reading:
